Background. Patients with cirrhosis have a high risk of hepatocellular carcinoma (HCC) but it is unclear how the etiology of liver disease influences tumor development. The authors evaluated hepatitis B and C virus (HBV, HCV) infection in cirrhosis in relation to the risk of HCC. Methods. Two hundr
Plasma Adipokines and Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Virus-Infected Carriers: A Prospective Study in Taiwan
β Scribed by Chen, C.-L.; Yang, W.-S.; Yang, H.-I.; Chen, C.-F.; You, S.-L.; Wang, L.-Y.; Lu, S.-N.; Liu, C.-J.; Kao, J.-H.; Chen, P.-J.; Chen, D.-S.; Chen, C.-J.
- Book ID
- 124095540
- Publisher
- American Association for Cancer Research
- Year
- 2014
- Tongue
- English
- Weight
- 887 KB
- Volume
- 23
- Category
- Article
- ISSN
- 1055-9965
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Some individuals who are chronically infected with hepatitis B virus (HBV) eventually lose hepatitis B surface antigen (HBsAg). Hepatocellular carcinoma (HCC) has been demonstrated to occur in a few patients after loss of HBsAg. Neither factors associated with loss of HBsAg nor the incidence of HCC
The age-specific prevalence of hepatitis B e antigen (HBeAg) and its antibody (anti-HBe) were studied by radioimmunoassay, and compared in a large series of patients with chronic hepatitis B virus (HBV) infection, including 268 asymptomatic carriers, 389 chronic hepatitis, 114 liver cirrhosis, and 2